BioTaiwan, an exhibition that showcases the nation’s biotechnology industry and matches buyers, researchers and local manufactures, opened in Taipei yesterday.
The four-day exhibition — dubbed Asia’s largest biotechnology fair with 600 exhibitors — is expected to attract 90,000 visitors, who are to see the latest developments in drugs and biopharmaceuticals, diagnostics, and medical devices and instruments
The visitors will also have the chance to gain an understanding of the investment and legal frameworks of the industry in Taiwan, as well as the development of science parks and incubation centers, the organizers said.
Taiwan Fertilizer Co (台肥) introduced its new bottled mineral water at the exhibition yesterday.
The state-run company said that the new bottled mineral water is among the fruits of its 20-year effort in biotechnology research.
The product is made from mineral-rich ocean water extracted from a depth of 200m off the coast of Hualien’s Chishingtan Beach, the company said.
The exhibition is being held jointly at the Taipei World Trade Center’s Nangang Exhibition Hall with the Taipei International Healthcare and Medical Cosmetology Expo, which highlights cosmetics products, equipment and herbal supplements.
On Wednesday, experts shared global trends in the sector at a two-day BioBusiness Asia Conference opened ahead of the exhibition, with Edgar Engleman, a founding member of the healthcare investment firm Vivo Capital LLC, saying that Taiwan’s strength lies in its medical care, but adding that the nation needs to improve its drug development, because often the first stage of clinical trials are conducted abroad.
David Flores, co-founder, president and chief executive officer of the industry information provider BioCentury Inc, urged a relaxation of regulations on clinical trials, while suggesting the need for the local capital market to become more open to global investment.
Flores, attending the conference for the third consecutive year, said there is growing competition among nations in their development of the biotechnology sector, adding that cross-border cooperation is key to pushing development forward.
TaiGen Biotechnology Co (太景生技) chief executive officer Hsu Ming-chu (許明珠) said the small size of Taiwan's pharmaceutical market means that local companies need to more actively seek opportunities for overseas expansion.
Enty to the exhibitions is free.
Additional reporting by Ted Chen
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said its materials management head, Vanessa Lee (李文如), had tendered her resignation for personal reasons. The personnel adjustment takes effect tomorrow, TSMC said in a statement. The latest development came one month after Lee reportedly took leave from the middle of last month. Cliff Hou (侯永清), senior vice president and deputy cochief operating officer, is to concurrently take on the role of head of the materials management division, which has been under his supervision, TSMC said. Lee, who joined TSMC in 2022, was appointed senior director of materials management and
Nvidia Corp CEO Jensen Huang (黃仁勳) on Thursday met with US President Donald Trump at the White House, days before a planned trip to China by the head of the world’s most valuable chipmaker, people familiar with the matter said. Details of what the two men discussed were not immediately available, and the people familiar with the meeting declined to elaborate on the agenda. Spokespeople for the White House had no immediate comment. Nvidia declined to comment. Nvidia’s CEO has been vocal about the need for US companies to access the world’s largest semiconductor market and is a frequent visitor to China.
Hypermarket chain Carrefour Taiwan and upscale supermarket chain Mia C’bon on Saturday announced the suspension of their partnership with Jkopay Co (街口支付), one of Taiwan’s largest digital payment providers, amid a lawsuit involving its parent company. Carrefour and Mia C’bon said they would notify customers once Jkopay services are reinstated. The two retailers joined an array of other firms in suspending their partnerships with Jkopay. On Friday night, popular beverage chain TP Tea (茶湯會) also suspended its use of the platform, urging customers to opt for alternative payment methods. Another drinks brand, Guiji (龜記), on Friday said that it is up to individual
READY TO BUY: Shortly after Nvidia announced the approval, Chinese firms scrambled to order the H20 GPUs, which the company must send to the US government for approval Nvidia Corp chief executive officer Jensen Huang (黃仁勳) late on Monday said the technology giant has won approval from US President Donald Trump’s administration to sell its advanced H20 graphics processing units (GPUs) used to develop artificial intelligence (AI) to China. The news came in a company blog post late on Monday and Huang also spoke about the coup on China’s state-run China Global Television Network in remarks shown on X. “The US government has assured Nvidia that licenses will be granted, and Nvidia hopes to start deliveries soon,” the post said. “Today, I’m announcing that the US government has approved for us
RSS